All Stories

  1. Insights into the Emerging Therapeutic Targets of Triple-negative Breast Cancer

    Article • Current Cancer Drug Targets, January 2025, Bentham Science Publishers

    Chandrashekhar VM, Dr Praveen Thaggikuppe Krishnamurthy, Ashish Wadhwani

  2. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells

    Article • Drug Development and Industrial Pharmacy, November 2018, Taylor & Francis

    Dr Praveen Thaggikuppe Krishnamurthy, Sai Kiran Pindiprolu

  3. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes

    Article • Drug Development and Industrial Pharmacy, February 2018, Taylor & Francis

    Dr Praveen Thaggikuppe Krishnamurthy, Ashish Wadhwani, Sameer Varma

  4. Soluble epoxide hydrolase inhibitor,t-TUCB, protects against myocardial ischaemic injury in rats

    Article • Journal of Pharmacy and Pharmacology, April 2014, Wiley

    Dr Praveen Thaggikuppe Krishnamurthy

  5. Novel Glitazones with Diverse Peroxisome Proliferator Activated Receptor Modulatory Potential

    Article • Current Bioactive Compounds, January 2014, Bentham Science Publishers

    Dr Praveen Thaggikuppe Krishnamurthy

  6. Newer Approaches to the Discovery of Glitazones

    Article • Mini-Reviews in Organic Chemistry, March 2013, Bentham Science Publishers

    Dr Praveen Thaggikuppe Krishnamurthy

  7. Antioxidant Enzymes and Human Health

    Article • October 2012, IntechOpen

    Dr Praveen Thaggikuppe Krishnamurthy

  8. The role of drugs in the induction and/or exacerbation of psoriasis

    Article • International Journal of Dermatology, November 2010, Wiley

    Dr Praveen Thaggikuppe Krishnamurthy

  9. Hepatoprotective activity of petroleum ether, diethyl ether, and methanol extract of Scoparia dulcis L. against CCl4-induced acute liver injury in mice

    Article • Indian Journal of Pharmacology, January 2009, Medknow

    Dr Praveen Thaggikuppe Krishnamurthy

  10. Serum glucose and triglyceride lowering activity of some novel glitazones against dexamethasone-induced hyperlipidemia and insulin resistance

    Article • Indian Journal of Pharmacology, January 2007, Medknow

    Dr Praveen Thaggikuppe Krishnamurthy